US drug delivery product demand will rise 7.4 percent yearly to $134 billion
in 2015. Parenteral products will grow the fastest, led by monoclonal
antibodies and polymer-encapsulated medicines. Other types expected to do well
include prefilled dry powder and metered dose brachytherapy implants, and
implantable drug delivery products.
This study analyzes the $93.8 billion US drug delivery system industry. It
presents historical demand data for the years 2000, 2005 and 2010, and
forecasts for 2015 and 2020 by excipient (e.g., polymers, cellulose,
minerals), product type (e.g., oral, parenteral, inhalation, implantable,
transdermal) and application (e.g., central nervous system, respiratory,
hormones, gastrointestinal).
The study also considers market environment factors, details industry
structure, evaluates company market share and profiles 27 industry players,
including Roche, GlaxoSmithKline and Becton Dickinson.
Table of Contents
Table of Contents
INTRODUCTION
I. EXECUTIVE SUMMARY
II. MARKET ENVIRONMENT
General
Economic Factors
Demographic Patterns
Health Care Trends
Health Insurance
Medical Conditions
Acute Conditions
Chronic Conditions
National Health Expenditures
Medical Providers
Hospitals
Skilled Nursing Homes
Outpatient Facilities
Physicians
Patient Activity
Hospital Activity
Surgical Procedures
Outpatient Consultations
Pharmaceutical Market Overview
Regulation
Research & Development
Demand Patterns
Therapeutic Classes
Dosage Formulations
Distribution Classification
Commercial Status
III. DRUG DELIVERY EXCIPIENTS
General
Polymers
Polyethylene Glycol
Acrylic Polymers
Carbomers
Methacrylate Copolymers
Polyethylene Oxide
Polyvinyl Alcohol
Other Synthetic Polymers
Cellulose Excipients
Ethyl Cellulose
Hydroxypropyl Methylcellulose (HPMC)
Other Cellulose Excipients
Minerals
Mineral Hydrocarbons
Petrolatum
Mineral Oil
Waxes
Other Minerals
Attapulgite
Calcium Carbonate
Calcium Silicate
Electrolytes
Other Excipients
Sterile & Purified Waters
Starch Compounds
Cyclodextrins
Dextrates
Dextrin
Maltodextrin
Sugars & Polyols
Sucrose
Sorbitol
Lactose
Mannitol
Natural Gums
All Other Excipients
IV. DRUG DELIVERY PRODUCTS OVERVIEW
General
Types of Drug Delivery Products
Historical Market Trends
Regulation
Research & Development
US Trade
International Markets
V. ORAL DRUG DELIVERY PRODUCTS
General
Controlled-Release Formulations
Coated Products
Diffusion Products
Reservoir Products
Chewable Tablets
Nanoparticulate Formulations
Orally Disintegrating Tablets (ODT)
Transmucosal Formulations
VI. PARENTERAL DRUG DELIVERY PRODUCTS
General
Therapeutic Monoclonal Antibodies
Types of Monoclonal Antibodies
Marketed Products
Therapeutic Monoclonal Antibodies in Development
Encapsulated Parenteral Drug Delivery Products
Polymer-Protected Products
PEG-Based Parenteral Therapies
Other Polymer-Protected Parenteral Therapies
Developmental Activities
Liposomes
Marketed Products
Developmental Activities
Infusion Products
IV Administration Sets
Premixed IV Solutions
Infusion Pumps
Other Infusion Products
Enteral Feeding Supplies
IV Accessories
Parenteral Drug Delivery Devices
Prefillable Syringes
Injectors
Cartridges
Hypodermic Syringes
IV Catheters
Other Parenteral Delivery Devices
VII. OTHER DRUG DELIVERY PRODUCTS
General
Inhalation Drug Delivery Products
Dry Powder Formulations
Types of DPIs
Developmental Activities
Metered Dose Formulations
3M Drug Delivery Systems
Other Producers
Implantable Drug Delivery Products
Drug-Eluting Stents
Other Implantable Drug Delivery Products
Drug Inserts
Brachytherapy
Drug Pumps
Transdermal Drug Delivery Products
Transdermal Technologies
Central Nervous System Agents
Other Transdermal Therapies
Hormones & Related Agents
OXYTROL 195
Cardiovascular Agents
Nicotine Patches
Scopolamine
VIII. APPLICATIONS
General
Central Nervous System Agents
Respiratory Agents
Hormones & Related Agents
Gastrointestinal Agents
Cardiovascular Agents
Anti-Infective Agents
Nutritional Agents
Genito-Urinary Agents
Other Pharmaceuticals
IX. INDUSTRY STRUCTURE
General
Market Share
Competitive Strategies
Mergers & Acquisitions
Licensing & Related Agreements
Marketing & Distribution
Manufacturing
Company Profiles
Abbott Laboratories
Amgen Incorporated
Aptalis Pharma Incorporated
AptarGroup Incorporated
AstraZeneca plc
Aveva Drug Delivery Systems, see Nitto Denko
Axcan Intermediate Holdings, see Aptalis Pharma
Baxa, see Baxter International
Baxter International Incorporated
Becton, Dickinson and Company
Boehringer Ingelheim GmbH
Boston Scientific Corporation
Braun (B.) Melsungen AG
Bristol-Myers Squibb Company
Cephalon, see Teva Pharmaceutical Industries
Conor Medsystems, see Johnson & Johnson
Cordis, see Johnson & Johnson
Eurand, see Aptalis Pharma
Evonik Industries AG
Facet Biotech, see Abbott Laboratories
Genentech, see Roche Holding
Genzyme, see Sanofi-Aventis
GlaxoSmithKline plc
Hospira Incorporated
ImClone Systems, see Lilly (Eli)
Janssen Pharmaceuticals, see Johnson & Johnson
Johnson & Johnson
Lilly (Eli) and Company
Medingo, see Roche Holding
Merck & Company Incorporated
Nitto Denko Corporation
Novartis AG
Novo Nordisk A/S
Ortho-McNeil-Janssen Pharmaceuticals, see Johnson & Johnson
Pfizer Incorporated
Roche Holding Limited
Sanofi-Aventis
Teva Pharmaceutical Industries Limited
3M Company
Unilife Corporation
West Pharmaceutical Services Incorporated
LIST OF TABLES
SECTION I -- EXECUTIVE SUMMARY
Summary Table
SECTION II -- MARKET ENVIRONMENT
1 Macroeconomic Indicators
2 Population by Age Group
3 Health Insurance Coverage of the US Population
4 Acute Conditions by Type
5 Chronic Conditions by Type
6 National Health Expenditures by Type
7 Medical Providers by Type
8 Patient Activity by Type & Volume
9 Pharmaceutical Demand by Therapeutic Class
10 Pharmaceutical Demand by Dosage Formulation
11 Pharmaceutical Demand by Distribution Classification
12 Pharmaceutical Demand by Commercial Status
SECTION III -- DRUG DELIVERY EXCIPIENTS
1 Drug Delivery Excipient Demand by Product Group
2 Polymer Drug Delivery Excipient Demand by Type
3 Cellulose Drug Delivery Excipient Demand by Type
4 Mineral Drug Delivery Excipient Demand by Type
5 Other Drug Delivery Excipient Demand by Type
SECTION IV -- DRUG DELIVERY PRODUCTS OVERVIEW
1 Drug Delivery Product Demand by Dosage Formulation
2 Drug Delivery Product Demand, 2000-2010
3 US Trade in Drug Delivery Products
4 World Drug Delivery Product Demand by Region
SECTION V -- ORAL DRUG DELIVERY PRODUCTS
1 Oral Drug Delivery Product Demand by Type
2 Oral Controlled-Release Drug Delivery Product Demand by Type, Mode of
Action & Application
3 Oral Coated Drug Delivery Product Demand
4 Oral Diffusion Drug Delivery Product Demand
5 Oral Reservoir Drug Delivery Product Demand
6 Chewable Tablet Demand by Therapeutic Class
7 Oral Nanoparticulate Product Demand by Application
8 Orally Disintegrating Tablet (ODT) Demand by Application
9 Transmucosal Product Demand
SECTION VI -- PARENTERAL DRUG DELIVERY PRODUCTS
1 Parenteral Drug Delivery Product Demand by Type
2 Therapeutic Monoclonal Antibody Demand by Application
3 Therapeutic Monoclonal Antibodies Approved for US Sale
4 Encapsulated Parenteral Product Demand by Type & Application
136
5 Infusion Product Demand by Type
6 Parenteral Delivery Device Demand by Type
SECTION VII -- OTHER DRUG DELIVERY PRODUCTS
1 Other Drug Delivery Product Demand by Type
2 Inhalation Drug Delivery Product Demand by Type
3 Dry Powder Inhaler (DPI) Product Demand
4 Metered Dose Inhaler (MDI) Product Demand
5 Implantable Drug Delivery Product Demand by Type & Application
6 Drug-Eluting Stent Demand 180
7 Other Implantable Drug Delivery Product Demand by Type
8 Transdermal Product Demand by Application
SECTION VIII -- APPLICATIONS
1 Drug Delivery Product Demand by Application
2 Central Nervous System (CNS) Drug Delivery Product Demand by Type
3 Respiratory Drug Delivery Product Demand by Type
4 Hormone & Related Drug Delivery Product Demand by Type
5 Gastrointestinal Drug Delivery Product Demand by Type
6 Cardiovascular Drug Delivery Product Demand by Type
7 Anti-Infective Drug Delivery Product Demand by Type
8 Nutritional Drug Delivery Product Demand by Type
9 Genito-Urinary Drug Delivery Product Demand by Type
10 Drug Delivery Product Demand in Other Pharmaceuticals by Type
SECTION IX -- INDUSTRY STRUCTURE
1 US Drug Delivery Product Sales by Company, 2010
2 Selected Acquisitions & Divestitures
3 Selected Cooperative Agreements
LIST OF CHARTS
SECTION IV -- DRUG DELIVERY PRODUCTS OVERVIEW
1 Drug Delivery Product Demand by Dosage Formulation, 2010
SECTION V -- ORAL DRUG DELIVERY PRODUCTS
1 Oral Drug Delivery Product Demand by Type, 2010
2 Oral Controlled-Release Drug Delivery Product Demand by Type, 2010
SECTION VI -- PARENTERAL DRUG DELIVERY PRODUCTS
1 Parenteral Drug Delivery Product Demand by Type, 2010
SECTION VII -- OTHER DRUG DELIVERY PRODUCTS
1 Other Drug Delivery Product Demand by Type, 2010
SECTION VIII -- APPLICATIONS
1 Drug Delivery Product Demand by Application, 2010
SECTION IX -- INDUSTRY STRUCTURE
1 Drug Delivery Dosage Formulations, US Market Share, 2010
2 Drug Delivery Devices, US Market Share, 2010
Drug Delivery Systems to 2015 published by The Freedonia Group in February 6, 2012. This report consists of 337 Pages and the price starts from US $ 4800.
